Year in Review: Atopic Dermatitis

(MedPage Today) -- New therapies, expanding uses for existing therapies, and links between atopic dermatitis (AD) and multiple inflammatory conditions have made headlines so far this year.
IL-13 Inhibitor Impresses in Phase III Trials
Favorable...

Source: MedPage Today Dermatology - November 2, 2023 Category: Dermatology Source Type: news